Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells

Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells

Pancreatic ductal adenocarcinoma (PDAC) is the most frequent pancreatic cancer type, characterized by a dismal prognosis due to late diagnosis, frequent metastases, and limited therapeutic response to standard chemotherapy. Circulating tumor cells (CTCs) are a rare subset of tumor cells found in the...

Full description

Bibliographic Details
Main Authors:	Dannel Yeo, Althea Bastian, Heidi Strauss, Payal Saxena, Peter Grimison, John E. J. Rasko
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	International Journal of Molecular Sciences
Subjects:	liquid biopsy biomarker prognosis screening stem cell organoids
Online Access:	https://www.mdpi.com/1422-0067/23/3/1671

Similar Items

Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imaging
by: Dannel Yeo, et al.
Published: (2023-03-01)

Updates on Clinical Use of Liquid Biopsy in Colorectal Cancer Screening, Diagnosis, Follow-Up, and Treatment Guidance
by: Omayma Mazouji, et al.
Published: (2021-05-01)

High mutation burden of circulating cell‐free DNA in early‐stage breast cancer patients is associated with a poor relapse‐free survival
by: Jouni Kujala, et al.
Published: (2020-08-01)

Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
by: Lavanya Sivapalan, et al.
Published: (2022-04-01)

Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review
by: Jinshou Yang, et al.
Published: (2021-12-01)

Circulating Nucleic Acids as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma
by: Ryan McGowan, et al.
Published: (2022-04-01)

Editorial: Circulating biomarkers in prostate cancer
by: Masayoshi Nagata, et al.
Published: (2024-02-01)

Circulating Non-coding RNAs in Renal Cell Carcinoma—Pathogenesis and Potential Implications as Clinical Biomarkers
by: Dominik A. Barth, et al.
Published: (2020-09-01)

Prognostic and Monitoring Value of Circulating Tumor Cells in Adrenocortical Carcinoma: A Preliminary Monocentric Study
by: Giulia Cantini, et al.
Published: (2020-10-01)

Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer
by: Carolina Maria Sassu, et al.
Published: (2021-12-01)

Molecular and Circulating Biomarkers in Patients with Glioblastoma
by: Nadia Senhaji, et al.
Published: (2022-07-01)

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer
by: Isabel Heidrich, et al.
Published: (2021-09-01)

The utility of liquid biopsy-based methylation biomarkers for colorectal cancer detection
by: Holli A. Loomans-Kropp, et al.
Published: (2024-03-01)

Cell-free DNA as a potential biomarker of differentiation and toxicity in cardiac organoids
by: Brian Silver, et al.
Published: (2023-06-01)

Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
by: Miguel Sogbe, et al.
Published: (2024-04-01)

Serum autoantibody profiling of oral squamous cell carcinoma patients reveals NUBP2 as a potential diagnostic marker
by: Riaz Abdulla, et al.
Published: (2023-09-01)

Circulating Tumor Cell Detection Technologies and Clinical Utility: Challenges and Opportunities
by: Zeina Habli, et al.
Published: (2020-07-01)

Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
by: Milena Matuszczak, et al.
Published: (2021-07-01)

Metabolomic biomarkers in liquid biopsy: accurate cancer diagnosis and prognosis monitoring
by: Wenqian Wang, et al.
Published: (2024-02-01)

Biomarkers of gastric cancer: current advancement
by: Tiantian Jiang, et al.
Published: (2022-10-01)

The Significance of Exosomes in Pathogenesis, Diagnosis, and Treatment of Esophageal Cancer
by: Jing Z, et al.
Published: (2021-09-01)

Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives
by: Verena Martini, et al.
Published: (2019-10-01)

Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision Medicine
by: Maria Panagopoulou, et al.
Published: (2021-02-01)

Overexpression of BCL2, BCL6, VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival
by: Cerón R, et al.
Published: (2022-12-01)

Post-Surgery Circulating Tumor Cells and <i>AXL</i> Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma
by: Diego de Miguel-Pérez, et al.
Published: (2019-11-01)

NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging
by: Anna Malczewska, et al.
Published: (2019-04-01)

Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients
by: Frederik J. Hansen, et al.
Published: (2023-01-01)

Biomarkers for Gastric Cancer Screening and Early Diagnosis
by: Cristina Herrera-Pariente, et al.
Published: (2021-10-01)

Ultra Deep Sequencing of Circulating Cell-Free DNA as a Potential Tool for Hepatocellular Carcinoma Management
by: Mónica Higuera, et al.
Published: (2022-08-01)

Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer
by: María Victoria García-Ortiz, et al.
Published: (2023-07-01)

Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future Perspectives
by: Koji Miyabayashi, et al.
Published: (2021-06-01)

The functional and clinical roles of liquid biopsy in patient-derived models
by: Ziqing Zhu, et al.
Published: (2023-04-01)

A liquid biopsy for detecting circulating mesothelial precursor cells: A new biomarker for diagnosis and prognosis in mesothelioma
by: Bill T.V. Duong, et al.
Published: (2020-11-01)

Circulating Tumor Cells for Glioma
by: Huikai Zhang, et al.
Published: (2021-03-01)

Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements
by: Natalia O. Tuaeva, et al.
Published: (2019-10-01)

Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer
by: Giulia Cantini, et al.
Published: (2021-06-01)

Exploring the Role of Hypoxia-Inducible Carbonic Anhydrase IX (CAIX) in Circulating Tumor Cells (CTCs) of Breast Cancer
by: Julianne D. Twomey, et al.
Published: (2023-03-01)

Establishment of Pancreatic Organoids from Normal Tissue and Tumors
by: Else Driehuis, et al.
Published: (2020-12-01)

Identification and validation of circulating exosomes‐based liquid biopsy for esophageal cancer
by: An Zhao, et al.
Published: (2019-07-01)

Clinical Implications of Circulating Circular RNAs in Lung Cancer
by: Sae Seul Choi, et al.
Published: (2022-04-01)